2,3,5,6-Tetrachloropyridine → HCID 58484556, 화합물

HRID 1804345노트

반응식

HRID 1804345 반응식
[CH3:1][O:2][CH2:3][C@@H:4]1[CH2:8][O:7][C:6](=[O:9])[N:5]1[C:10]1[CH:15]=[CH:14][C:13]([C:16]([N:18]2[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]2)=[O:17])=[CH:12][CH:11]=1.[Cl:24][C:25]1[C:30]([Cl:31])=[CH:29][C:28]([Cl:32])=[C:27](Cl)[N:26]=1>>[CH3:1][O:2][CH2:3][C@@H:4]1[CH2:8][O:7][C:6](=[O:9])[N:5]1[C:10]1[CH:15]=[CH:14][C:13]([C:16]([N:18]2[CH2:19][CH2:20][N:21]([C:27]3[C:28]([Cl:32])=[CH:29][C:30]([Cl:31])=[C:25]([Cl:24])[N:26]=3)[CH2:22][CH2:23]2)=[O:17])=[CH:12][CH:11]=1

참가 물질

3

실험 절차

By reaction and treatment in the same manner as in Example 147 and using (R)-4-methoxymethyl-3-[4-(piperazine-1-carbonyl)phenyl]oxazolidin-2-one (972 mg) described in Preparation Example 165 and 2,3,5,6-tetrachloropyridine (990 mg), the title compound (1.25 g) was obtained.

후처리

  1. customBy reaction and treatment in the same manner as in Example 147

출처 및 근거

ORD 기록
ord-4548ad9a597f4d519abea4dbc5acc91d
출처 데이터셋
uspto-grants-2013_01
특허 번호
US08354401B2

반응 노트

불러오는 중…